Product Description |
Recombinant CHO-K1 cells stably overexpress human bombesin receptor subtype 3 (BB3) on the surface and contain high levels of G protein Gαq to couple with the receptor in downstream signaling pathways. |
Applications |
Calcium mobilization assay. |
Expressed Gene |
NCBI reference sequence NM_001727; no expressed tags |
Target Protein |
NP_001718 |
Host Cell |
CHO-K1 |
Size |
Two vials of frozen cells (>1×106 per vial in 1 mL) |
Storage |
Store cells in liquid nitrogen immediately upon receipt. Thaw and recover cells within one year from the date received. |
Mycoplasma Status |
Negative. The mycoplasma test was performed with MycoAlert™ PLUS Mycoplasma Detection Kit (Cat. No. LT07-318, Lonza). |
Stability |
Stable through more than 16 passages with no significant changes in assay performance or expression profile. |
Culture Properties |
Adherent |
Freeze Medium |
45% Ham’s F-12K (Kaighn’s) (Cat. No. 21127, Life Technologies), 45% FBS (Cat. No. 10099-141, Gibco), 10% DMSO (Cat. No. D2650, Sigma) |
Complete Growth Medium |
Ham’s F-12K (Kaighn’s), 10% FBS |
Culture Medium |
Ham’s F-12K (Kaighn’s), 10% FBS, 400 μg/ml G418 (Cat. No. 10131-035, Gibco) |
Gene Synonyms |
BRS3; BB3R; BBR3 |
Background |
Bombesin, a bioactive peptide first identified in amphibian skin, is related to two mammalian peptides, gastrin-releasing peptide (GRP) and neuromedin B. A family of 4 GPCRs, including NMB-R (BB1), GRP-R (BB2), BRS-3 (BB3) and BRS-4, mediates the biological effects of the peptides. The bombesin receptor subtype 3, BB3 (also known as BRS3), is a third mammalian bombesin receptor subtype and no endogenous ligand has been identified to date. BB3 expression has been reported in lung (normal and cancer), nasal mucosa, placenta, and uterus. BB3-null mice have an obese phenotype, which suggests that BB3 may be an important target for obesity research. In addition, BB3 may be involved in diabetes and hypertension. |

Figure 1: Neuromedin B-induced concentration-dependent stimulation of intracellular calcium mobilization in CHO-K1/BB3 cells. The cells were loaded with Calcium-4 prior to stimulation with a BB3 receptor agonist, Neuromedin B. The intracellular calcium change was measured by FLIPRTETRA. The relative fluorescent units (RFU) were normalized and plotted against the log of the cumulative doses (5-fold dilution) of Neuromedin B (Mean ± SEM, n = 3). The EC50 of Neuromedin B on this cell was 0.33 μM.
Notes:
EC50 value is calculated with four parameter logistic equation:
Y=Bottom + (Top-Bottom) / (1+10^((LogEC50-X)*Hill Slope))
X is the logarithm of concentration. Y is the response
Y is % stimulation of RFU and starts at Bottom and goes to Top with a sigmoid shape.
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
如您需要获取细胞系产品的说明书,请点击“Manual”,完善信息后点击“提交”。
我们会第一时间联系回复您。注意:中国地区购买的产品,说明书需要以中文站为准。
您也可拨打400-0258686转5810,或发邮件至product@genscript.com.cn联系我们。
更多产品文件类型 >>